###begin article-title 0
Deletion of the N-terminus of SF2/ASF Permits RS-Domain-Independent Pre-mRNA Splicing
###end article-title 0
###begin p 1
Conceived and designed the experiments: AK SS. Performed the experiments: SS. Analyzed the data: SS. Wrote the paper: AK SS. Other: Designed and generated N-terminal deletion construct: SC GG.
###end p 1
###begin p 2
###xml 738 746 738 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1556 1564 1556 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Serine/arginine-rich (SR) proteins are essential splicing factors with one or two RNA-recognition motifs (RRMs) and a C-terminal arginine- and serine-rich (RS) domain. SR proteins bind to exonic splicing enhancers via their RRM(s), and from this position are thought to promote splicing by antagonizing splicing silencers, recruiting other components of the splicing machinery through RS-RS domain interactions, and/or promoting RNA base-pairing through their RS domains. An RS domain tethered at an exonic splicing enhancer can function as a splicing activator, and RS domains play prominent roles in current models of SR protein functions. However, we previously reported that the RS domain of the SR protein SF2/ASF is dispensable for in vitro splicing of some pre-mRNAs. We have now extended these findings via the identification of a short inhibitory domain at the SF2/ASF N-terminus; deletion of this segment permits splicing in the absence of this SR protein's RS domain of an IgM pre-mRNA substrate previously classified as RS-domain-dependent. Deletion of the N-terminal inhibitory domain increases the splicing activity of SF2/ASF lacking its RS domain, and enhances its ability to bind pre-mRNA. Splicing of the IgM pre-mRNA in S100 complementation with SF2/ASF lacking its RS domain still requires an exonic splicing enhancer, suggesting that an SR protein RS domain is not always required for ESE-dependent splicing activation. Our data provide additional evidence that the SF2/ASF RS domain is not strictly required for constitutive splicing in vitro, contrary to prevailing models for how the domains of SR proteins function to promote splicing.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zahler1">[1]</xref>
###xml 193 196 193 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Birney1">[2]</xref>
###xml 279 282 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley1">[3]</xref>
###xml 487 490 487 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cartegni1">[4]</xref>
###xml 491 494 491 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Fu1">[9]</xref>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Hargous1">[10]</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Reed1">[11]</xref>
###xml 996 998 996 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1075 1079 1075 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Wu1">[12]</xref>
###xml 1081 1085 1081 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Kohtz1">[13]</xref>
###xml 1258 1262 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Staknis1">[14]</xref>
###xml 1338 1346 1338 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1346 1350 1346 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Xiao1">[15]</xref>
###xml 1410 1412 1410 1412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 1502 1504 1502 1504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1504 1508 1504 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zuo1">[16]</xref>
###xml 1510 1514 1510 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Wang1">[17]</xref>
###xml 1516 1520 1516 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Bouck1">[18]</xref>
###xml 1561 1563 1561 1563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 1743 1747 1743 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Tian1">[19]</xref>
###xml 1749 1753 1749 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Lorson1">[20]</xref>
###xml 1755 1759 1755 1759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley2">[21]</xref>
###xml 1881 1885 1881 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Li1">[22]</xref>
###xml 1887 1891 1887 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Kan1">[23]</xref>
###xml 1993 1995 1993 1995 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 2229 2233 2229 2233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Hertel1">[24]</xref>
###xml 801 806 <span type="species:ncbi:4932">yeast</span>
The SR proteins are a family of conserved splicing factors that consist of either one or two N-terminal RNA recognition motifs (RRM) and a C-terminal arginine- and serine-rich (RS) domain [1], [2]. SR proteins promote constitutive and alternative splicing through multiple modes [3], some of which are presumed to require their RS domains. Exonic splicing enhancers (ESEs) are degenerate 6-8 nucleotide motifs that promote exon inclusion, in many cases through the action of SR proteins [4]-[9]. SR proteins bind to ESEs via their RRM(s) [10], whereas their RS domains are thought to function as protein-protein interaction modules that facilitate exon inclusion by recruiting components of the basal splicing machinery to the flanking 5' and 3' splice sites early in splice-site recognition [11]. In yeast two-hybrid and Far Western assays, the SR protein SF2/ASF was shown to interact with itself and with the U1-snRNP-specific protein U1-70K and the small subunit of the U2AF heterodimer, U2AF35; these protein-protein interactions required the RS domains of each protein [12], [13]. Subsequently it was proposed that SR proteins can promote recruitment of the U1 snRNP to the 5' splice site through SR protein RS-domain-mediated interactions with U1-70K [14]. However, the RS domain of SF2/ASF alone is unable to interact with U1-70K in vitro[15]. Enhancer-bound SR proteins are also thought to escort U2AF65 to the 3' splice site polypyrimidine tract through RS-domain-mediated recruitment of U2AF35[16], [17], [18]. A role for SR proteins in bringing U2AF65 to the polypyrimidine tract is supported by several experiments in which improving this tract can relieve the requirement for an ESE for pre-mRNAs with enhancer-dependent introns [19], [20], [21]. However, other experiments failed to detect changes in U2AF recruitment in the presence versus in the absence of an ESE [22], [23], calling into question the hypothesis that an ESE-bound RS domain is required for recruitment of U2AF65. Although the aforementioned functions of SR proteins are assumed to occur via RS-domain-mediated protein-protein interactions, it has not yet been demonstrated that such interactions occur in the context of a functional spliceosome [24].
###end p 4
###begin p 5
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Pozzoli1">[25]</xref>
###xml 371 374 371 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cartegni1">[4]</xref>
###xml 505 508 505 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tat</italic>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zhu1">[26]</xref>
###xml 501 504 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A second mode by which SR proteins promote exon inclusion is by antagonizing the negative regulation conferred by exonic splicing silencers (ESSs), pre-mRNA regulatory elements that inhibit exon inclusion in both constitutive and alternative splicing [25]. Although the mechanisms by which SR proteins counteract the effects of splicing silencers are not well understood [4], their RS domains are not always required for this function, as SF2/ASF lacking its RS domain can act from the position of an HIV tat exon 3 ESE to antagonize an ESS present in the same exon [26].
###end p 5
###begin p 6
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen1">[27]</xref>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen2">[28]</xref>
###xml 835 839 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen1">[27]</xref>
###xml 1098 1103 1098 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 1242 1246 1242 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cartegni2">[29]</xref>
A third mechanism by which SR proteins have been reported to promote splicing is by engaging in transient RS domain-pre-mRNA contacts during the course of splicing. An ESE-bound RS domain can interact directly with the branchpoint of an IgM substrate in the pre-spliceosomal A complex [27]. The RS domains of SR proteins bound to ESEs can also act as protein-RNA interaction modules to promote base-pairing of pre-mRNA and U5 and U6 snRNAs during the course of pre-mRNA splicing [28]. However, although it is clear that an RS domain recruited to the ESE position can function as a splicing activator, an RS domain tethered to the position of the ESE is not always required, as splicing of the ESE-dependent substrate dsx lacking its ESE can also be accomplished simply by the addition of an excess of free RS domain to nuclear extract [27], consistent with the hypothesis that the function of an SR protein may be merely to recruit any RS domain to the vicinity of the splicing signal. On the other hand, adding an RS domain peptide to nuclear extract is insufficient to promote exon inclusion for BRCA1 pre-mRNA exon 18 lacking a functional ESE, whereas recruitment of a synthetic RS domain to the mutated ESE rescues inclusion of this exon [29].
###end p 6
###begin p 7
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Gui1">[30]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Wang2">[31]</xref>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Colwill1">[32]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Rossi1">[33]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Colwill1">[32]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Gui2">[34]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Misteli1">[35]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Ngo1">[36]</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Kanopka1">[37]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Prasad1">[38]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Sanford1">[39]</xref>
###xml 619 628 619 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro,</italic>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cceres1">[40]</xref>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zuo2">[41]</xref>
###xml 854 862 854 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 939 943 939 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zhu2">[42]</xref>
###xml 1239 1241 1235 1237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1241 1245 1237 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zhu2">[42]</xref>
###xml 1369 1371 1365 1367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1459 1463 1455 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Guth1">[43]</xref>
###xml 1465 1469 1461 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Guth2">[44]</xref>
The RS domains of SR proteins are conserved, and the serine residues within these domains are targets of phosphorylation by multiple kinases, including SRPK1 [30] and SRPK2 [31], Clk/Sty [32], and DNA topoisomerase I [33]. Phosphorylation of RS domains influences the subcellular localization of SR proteins [32], [34], [35], [36]. The phosphorylation state of the RS domain has a significant influence on SR protein function, as both hyper- and hypophosphorylated SR proteins are unable to support splicing [37], [38], [39]. SR protein RS domains were at one time thought to be indispensable for constitutive splicing in vitro, yet dispensable for concentration-dependent effects on alternative splice-site selection [40], [41]. However, we subsequently found that the RS domain of SF2/ASF is not required for constitutive splicing of several pre-mRNAs in vitro, including tat23, an ESE-dependent pre-mRNA known to be regulated by an ESS [42]. Thus, pre-mRNAs could be classified as either RS-domain-dependent or RS-domain-independent, based on their ability to be spliced with an SR protein lacking its RS domain ("DeltaRS"). RS-domain-dependence was found to be related to the strength of the 3' splice site and the requirement for U2AF35[42]. IgM M1-M2 was identified as an RS-domain-dependent pre-mRNA, congruent with at least some previous reports that it is U2AF35-dependent and possesses relatively weak polypyrimidine-tract and branchpoint sequences [43], [44].
###end p 7
###begin p 8
###xml 465 467 465 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 494 496 494 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley2">[21]</xref>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen3">[45]</xref>
###xml 807 809 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 818 820 818 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 849 853 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley2">[21]</xref>
###xml 912 914 912 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 977 981 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Kan1">[23]</xref>
IgM M1-M2 has been used by several laboratories as a model substrate to explore the role(s) of ESEs in promoting pre-mRNA splicing. However, the functions of the ESE-bound SR protein in the context of the RS-domain-dependent IgM M1-M2 pre-mRNA have been controversial, and there are several competing models for the mechanism by which SF2/ASF promotes splicing at the ESE position in this substrate. In the recruitment model, SF2/ASF binds via its RS domain to U2AF35 to indirectly recruit U2AF65 to the polypyrimidine tract [21], whereas in the antagonism model, the sole function of enhancer-bound SF2/ASF is to prevent PTB from binding to a downstream ESS [45]. Some experiments with the IgM M1-M2 substrate strongly support the model for SR protein function in which an ESE-bound RS domain recruits U2AF35 and U2AF65 to the polypyrimidine tract [21]. However, other experiments detected no difference in U2AF35 occupancy on IgM M1-M2 in the presence and absence of the ESE [23].
###end p 8
###begin p 9
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zhu2">[42]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Maris1">[46]</xref>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cceres1">[40]</xref>
###xml 870 874 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zhu2">[42]</xref>
###xml 1379 1387 1371 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
The discovery that many but not all substrates could be spliced with SF2/ASF lacking its RS domain [42] suggested that SR protein functions might be subdivided into RS-domain-dependent and RS-domain-independent categories. We prepared various fragments of SF2/ASF for structural and functional studies, including versions lacking the C-terminal RS domain and/or an N-terminal extension that precedes RRM1. N-terminal and C-terminal extensions of RRMs have been demonstrated to regulate nucleic acid binding in other splicing factors [46], and we noted that SF2/ASF and some other SR proteins have N-terminal RRM extensions. We had previously characterized an N-terminally His-tagged SF2/ASF lacking the RS domain as unable to complement S100 for constitutive splicing [40], but omitting this N-terminal tag allowed the same protein to support splicing of some pre-mRNAs [42]. These precedents suggested that the natural N-terminus of SF2/ASF may influence its activity, and we therefore investigated whether the N-terminal extension preceding RRM1 had any influence on the splicing activity of DeltaRS with the RS-domain-dependent substrate IgM M1-M2. Deletion of the N-terminus from DeltaRS revealed that the RS domain is not required for splicing of IgM M1-M2, lending further support to our previous finding that the RS domain of SF2/ASF is sometimes dispensable for splicing in vitro, and calling for a reevaluation of traditional models of SR protein function.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
The RS domain of SF2/ASF is not required for splicing of IgM M1-M2 in vitro
###end title 11
###begin p 12
###xml 187 195 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 212 220 208 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1</xref>
###xml 405 414 397 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1C</xref>
###xml 681 690 661 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1C</xref>
###xml 858 867 834 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1C</xref>
To determine whether the splicing activity of the DeltaRS protein is affected by the N-terminal extension to RRM1, we tested proteins with mutations and deletions of the N-terminus in an in vitro splicing assay (Figure 1). IgM M1-M2 was previously characterized as an RS-domain-dependent substrate, although a low level of splicing can be detected in S100 complementation assays with our DeltaRS protein (Figure 1C, lane 4), which consists of amino acids 1-196 of SF2/ASF. Deletion of the first 11 amino acids of DeltaRS to produce the DeltaNDeltaRS protein comprising amino acids 12-196 permitted splicing of IgM M1-M2 at a level comparable to that seen with full-length SF2/ASF (Figure 1C, lanes 2 and 5). Deletion of the N-terminus from SF2/ASF to produce the DeltaNSF2/ASF protein also slightly increased the amount of splicing supported by the protein (Figure 1C, lanes 2 and 3).
###end p 12
###begin title 13
Identification of N-terminal residues of SF2/ASF that contribute to the inhibitory function of this domain.
###end title 13
###begin p 14
###xml 117 125 117 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 386 394 386 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
(A) Amino acid sequence of the N-terminal extension of RRM1 of SF2/ASF, indicating mutations generated and tested by in vitro splicing and UV crosslinking assays. The first residues of RRM1 are in bold, with the RNP-2 submotif underlined. (B) Recombinant SF2/ASF and mutant proteins used in this study, analyzed by SDS-PAGE and Coomassie-blue staining. M: molecular-weight markers. (C) In vitro splicing of IgM M1-M2 pre-mRNA in HeLa S100 extract alone (lane 1), and in S100 complemented with 16 pmol of SF2/ASF, DeltaRS, and N-terminus mutant proteins, as indicated (lanes 2-19). The splicing efficiency is indicated below each lane.
###end p 14
###begin title 15
Mutational analysis of the N-terminus of SF2/ASF reveals that conserved amino acids contribute to the inhibitory effect of the RRM1 extension on splicing
###end title 15
###begin p 16
###xml 410 418 402 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1</xref>
###xml 1129 1146 1108 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figures 1A and 1B</xref>
###xml 1219 1227 1194 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1259 1268 1234 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1C</xref>
###xml 1513 1522 1488 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1C</xref>
###xml 1711 1720 1666 1675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1C</xref>
We observed that deletion of the 11 N-terminal amino acids (MSGGGVIRGPA) from SF2/ASF and DeltaRS increased the amount of splicing that could be supported by these proteins, suggesting that the N-terminus has an inhibitory function. To identify amino acids within this N-terminal region that may contribute to inhibition of splicing, we generated SF2/ASF and DeltaRS proteins with mutations in the N-terminus (Figure 1). Amino acids 5-10 (GVIRGP) are predicted to have beta-strand propensity (GOR4, Biology Workbench, San Diego Supercomputer Center, University of California at San Diego; Subramaniam, 1998), and several other proteins identified through a Basic Local Alignment Search Tool search (BLAST, National Center for Biotechnology Information) as having similar motifs to GVIRGP are known to adopt a beta-strand conformation with their homologous residues. We made both SF2/ASF and DeltaRS proteins with the following mutations at the N-terminus: deletion of amino acids 5-10 (the predicted beta-strand), a triple mutant of amino acids 6-8 called V6A/I7A/R8A, and single mutants designated V6A, I7A, R8A, P10A, and R8E (Figures 1A and 1B). The SF2/ASF and DeltaRS N-terminus mutant proteins were tested in the in vitro splicing assay with IgM M1-M2 (Figure 1C) to determine whether mutation of any of these amino acids relieves the inhibitory effect of the N-terminus. Most of the N-terminal mutations had little or no effect on the amount of splicing of IgM M1-M2 in the context of full-length SF2/ASF (Figure 1C, lanes 6-12). However, of the DeltaRS N-terminus mutant proteins, DeltaRS: Delta5-10 and DeltaRS:R8E showed a significant increase in splicing, relative to their parental protein DeltaRS (Figure 1C, lanes 13 and 19), with levels of splicing similar to that seen with DeltaNDeltaRS. The increase in splicing of IgM M1-M2 with these mutant proteins, relative to DeltaRS, suggests that residues within amino acids 5-10 contribute to the inhibitory effect of the N-terminus on splicing, and in particular, that R8 plays a role in this inhibition.
###end p 16
###begin p 17
###xml 107 115 107 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g002">Figure 2</xref>
We carried out a phylogenetic analysis to examine the conservation of the N-terminal extension of SF2/ASF (Figure 2). The N-terminal peptide is highly conserved in vertebrate SF2/ASF orthologs, but not in other SR protein paralogs. Invertebrate and plant SF2/ASF and a subset of other SR proteins also have N-terminal extensions, which in most cases include at least one arginine residue.
###end p 17
###begin title 18
Phylogenetic alignment of the N-termini of SF2/ASF orthologs and paralogs.
###end title 18
###begin p 19
SR protein N-terminal RRM extensions were aligned using ClustalW. Accession numbers are provided for each sequence in the alignment. Sequences in the beta1 strand and arginine residues in the extensions are indicated by bold lettering.
###end p 19
###begin title 20
The N-terminal extension of RRM1 influences the ability of SF2/ASF to bind RNA
###end title 20
###begin p 21
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Query1">[47]</xref>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Nagai1">[48]</xref>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Oubridge1">[49]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Jessen1">[50]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Simpson1">[51]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Gorlach1">[52]</xref>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Ding1">[53]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Jacks1">[54]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-PrezCaadillas1">[55]</xref>
###xml 800 808 772 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g003">Figure 3</xref>
###xml 940 949 908 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g003">Figure 3B</xref>
###xml 1246 1255 1198 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1C</xref>
###xml 1323 1332 1275 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g003">Figure 3B</xref>
Protein segments N-terminal or C-terminal to the core RRM module have been demonstrated to play roles in nucleic acid recognition for several splicing factors, including U1-70K [47], U1A [48], [49], [50], PTB [51], hnRNP C [52], and hnRNP A1 [53], as well as other RNA-binding proteins with RRMs, such as La [54] and CstF-64 [55]. As RRM extensions modulate the specificity of RNA binding, the binding affinity, and/or the accessibility of the RNA-binding surface for other nucleic acid-binding proteins, we hypothesized that the SF2/ASF N-terminal extension may influence the affinity of the protein for splicing substrates. The binding of purified recombinant SF2/ASF, DeltaNSF2/ASF, DeltaRS, DeltaNDeltaRS, DeltaRS: Delta5-10, and DeltaRS:R8E to IgM M1-M2 pre-mRNA was assayed by UV crosslinking (Figure 3). Although there was little difference between the extent of RNA crosslinking observed for the SF2/ASF and DeltaNSF2/ASF proteins (Figure 3B, lanes 2 and 3), deletion of the N-terminal extension in the context of the DeltaRS protein greatly increased the crosslinking to the IgM M1-M2 RNA (lanes 4 and 5). In addition, the DeltaRS: Delta5-10 protein, which exhibited increased splicing activity relative to its parental DeltaRS protein (Figure 1C, lane 13), was also more efficiently crosslinked to IgM M1-M2 RNA (Figure 3B, lane 6). These data suggest that the inhibitory effect of the N-terminus of the DeltaRS protein on splicing of IgM M1-M2 may be due to a negative influence of this segment on the protein's ability to bind RNA.
###end p 21
###begin title 22
DeltaRS N-terminus mutations that improve splicing also increase the ability of DeltaRS to bind IgM M1-M2.
###end title 22
###begin p 23
(A) Recombinant SF2/ASF and mutant proteins employed in the crosslinking assay. M: molecular-weight markers. (B) UV crosslinking of SF2/ASF and variant proteins to radiolabeled IgM M1-M2 RNA. BSA (lane 1), or purified recombinant SR proteins SF2/ASF (lane 2), DeltaNSF2/ASF (lane 3), DeltaRS (lane 4), DeltaNDeltaRS (lane 5), DeltaRS: Delta5-10 (lane 6), and DeltaRS:R8E (lane 7) were incubated with uncapped IgM M1-M2 RNA prior to crosslinking, RNAse digestion, and separation of crosslinked adducts by SDS-PAGE.
###end p 23
###begin p 24
###xml 75 84 71 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1C</xref>
###xml 341 350 329 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g003">Figure 3B</xref>
The increase in splicing observed with DeltaRS harboring the R8E mutation (Figure 1C, lane 19) was not strictly correlated with improvement in RNA binding as measured by UV crosslinking with purified recombinant proteins, as apparent binding of DeltaRS: R8E protein to IgM M1-M2 RNA was not greatly increased relative to binding of DeltaRS (Figure 3B, lanes 4 and 7). Increased apparent RNA binding in the UV crosslinking assay for DeltaNDeltaRS and DeltaRS: Delta5-10 proteins may be a consequence of removal of a portion of the inhibitory N-terminus, whereas the R8E mutation may not increase RNA binding to the same extent in this assay because it preserves the length of the inhibitory N-terminal extension to RRM1. On the other hand, the UV crosslinking assay with RNA and purified recombinant proteins does not necessarily address whether the R8E mutation affects the ability of the DeltaRS protein to be recruited to IgM M1-M2 pre-mRNA under splicing conditions.
###end p 24
###begin title 25
Splicing of IgM M1-M2 with DeltaNDeltaRS requires the exonic splicing enhancer
###end title 25
###begin p 26
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley2">[21]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley3">[56]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen4">[57]</xref>
###xml 422 425 418 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Liu2">[7]</xref>
###xml 427 431 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Kan1">[23]</xref>
###xml 433 437 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Watakabe1">[58]</xref>
###xml 439 443 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley4">[59]</xref>
###xml 445 449 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Chew1">[60]</xref>
###xml 753 757 741 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Kan1">[23]</xref>
###xml 1261 1270 1237 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1C</xref>
###xml 1365 1373 1333 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g004">Figure 4</xref>
###xml 1521 1529 1485 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g004">Figure 4</xref>
###xml 1666 1674 1618 1626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g004">Figure 4</xref>
Despite the fact that IgM M1-M2 was previously characterized as an RS-domain-dependent substrate, and although its splicing can be activated by an RS domain tethered to the position of its ESE [21], [56], [57], we have established through deletion of the N-terminus from DeltaRS that the RS domain of SF2/ASF is not required for IgM M1-M2 splicing. We and others have observed that IgM M1-M2 is an ESE-dependent substrate [7], [23], [58], [59], [60]. As several existing models for SR protein function in the IgM M1-M2 context require an enhancer-bound SR protein or RS domain, we wished to determine whether the DeltaNDeltaRS protein exerted its effects through the ESE. Therefore, we deleted the enhancer region (GAAGGACAGCAGAGACCAAGA, as reported in [23]) from IgM M1-M2 to produce the IgMDeltaE substrate, and tested its ability to be spliced with the DeltaNDeltaRS protein. We also mutated other sequences already demonstrated to have a relationship to SR protein function within the IgM M1-M2 pre-mRNA context, i.e., the polypyrimidine tract and the exonic splicing silencer, to test whether there was any difference in splicing with changes in these elements, in the presence or absence of the SF2/ASF RS domain. As already seen in the above experiment (Figure 1C), DeltaNDeltaRS complemented S100 for splicing of IgM M1-M2 almost as efficiently as SF2/ASF (Figure 4, lanes 2 and 3). As expected, IgMDeltaE could not be spliced in S100 complementation with SF2/ASF, because IgM M1-M2 is an ESE-dependent pre-mRNA (Figure 4, lane 5). Likewise, DeltaNDeltaRS could not splice IgMDeltaE, demonstrating that it also activates splicing in an ESE-dependent manner (Figure 4, lane 6).
###end p 26
###begin title 27
An exonic splicing enhancer is required for splicing of IgM M1-M2 with DeltaNDeltaRS.
###end title 27
###begin p 28
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro splicing of IgM M1-M2 and derivative pre-mRNAs with mutations in the polypyrimidine tract, exonic splicing enhancer, and/or exonic splicing silencer: IgM M1-M2 (lanes 1-3), IgMDeltaE (lanes 4-6), IgMPyupward arrow (lanes 7-9), IgMPyupward arrowDeltaE (lanes 10-12), IgMPTB (lanes 13-15), IgMDeltaEPTB (lanes 16-18), IgMPyupward arrowPTB (lanes 19-21), and IgMPyupward arrowDeltaE PTB (lanes 22-24, mRNA position indicated by asterisk); in S100 alone (lanes 1, 4, 7, 10, 13, 16, 19, and 22), and S100 complemented with 16 pmol of SF2/ASF (lanes 2, 5, 8, 11, 14, 17, 20, and 23), or DeltaNDeltaRS (lanes 3, 6, 9, 12, 15, 18, 21, and 24). The splicing efficiency is indicated below each lane.
###end p 28
###begin p 29
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Watakabe1">[58]</xref>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen3">[45]</xref>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Schneider1">[61]</xref>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen3">[45]</xref>
###xml 1006 1007 1006 1007 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 1008 1009 1008 1009 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 1013 1014 1013 1014 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 1015 1016 1015 1016 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen3">[45]</xref>
###xml 1246 1254 1226 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g004">Figure 4</xref>
###xml 1509 1513 1489 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen3">[45]</xref>
###xml 1632 1640 1600 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g004">Figure 4</xref>
###xml 2301 2305 2269 2273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley2">[21]</xref>
###xml 2307 2311 2275 2279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Watakabe1">[58]</xref>
The IgM M1-M2 ESS was originally identified in functional assays by progressive deletion of exonic sequences from the 3' end of the pre-mRNA, and mapped to the last half of the M2 exon [58]. The silencer was subsequently more precisely mapped to an 11-nucleotide motif denoted PTB site I (UCUUACGUCUU), and its cognate repressor protein was identified as pyrimidine tract binding protein (PTB) [45]. Using an IgM M1-M2 derivative substrate in which the ESE had been replaced by an MS2 bacteriophage coat protein binding site [61], Shen et al showed in S100 complementation assays with SF2/ASF that immunodepletion of PTB permitted splicing of IgM in the absence of an MS2-RS protein targeted to the ESE position [45], suggesting that the primary function of an SR protein bound at this ESE is to counteract the juxtaposed ESS. To determine whether the RS domain of an ESE-bound SR protein plays a role in antagonizing the function of the IgM M1-M2 ESS, we tested an IgM substrate with a mutant PTB site I (ACAUACGACAU, as in [45]), IgMPTB, and the PTB mutant substrate also lacking the ESE, IgMDeltaEPTB, in S100 complementation with SF2/ASF and DeltaNDeltaRS. More efficient splicing of IgMPTB was observed with DeltaNDeltaRS than with SF2/ASF (Figure 4, lanes 14 and 15), suggesting that the RS domain of SF2/ASF is not required for counteracting the function of the PTB site I silencing element. However, contrary to the previous report that the PTB site I mutation can relieve the requirement for the ESE [45], we did not observe splicing of IgMDeltaEPTB with either SF2/ASF or DeltaNDeltaRS in our S100 complementation assays (Figure 4, lanes 17 and 18). The discrepancies between our results and the previously reported data may be attributable to differences in the methods by which we tested the substrates; in their S100 complementation assays, Shen et al immunodepleted PTB from S100, rather than mutating the PTB site I. It is possible that mutation of the PTB site I might be insufficient to permit splicing in S100 complementation, for example, in a scenario in which PTB binds to additional sites in IgM M1-M2 to silence splicing. On the other hand, we note that our results are in agreement with other reports that an ESE is required for splicing of IgM, even in the absence of the ESS [21], [58].
###end p 29
###begin p 30
###xml 214 218 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley2">[21]</xref>
###xml 504 506 477 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 521 525 494 498 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UUUU</underline>
###xml 526 528 499 501 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UC</underline>
###xml 529 531 502 504 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CU</underline>
###xml 532 533 505 506 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</underline>
###xml 534 538 507 511 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UUUU</underline>
###xml 539 540 512 513 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 548 552 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley2">[21]</xref>
###xml 882 890 784 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g004">Figure 4</xref>
###xml 1183 1191 1047 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g004">Figure 4</xref>
###xml 1705 1709 1569 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen3">[45]</xref>
###xml 1745 1749 1609 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley2">[21]</xref>
We have demonstrated that DeltaNDeltaRS, like SF2/ASF, activates splicing in an ESE-dependent manner. As improvement of the polypyrimidine tract relieves the requirement for an enhancer when the ESS is not present [21], we attempted to relieve the requirement for the ESE for splicing of IgM M1-M2 by DeltaNDeltaRS by simultaneously improving the polypyrimidine tract and mutating the ESS. We generated the IgMPyupward arrow substrate, in which the polypyrimidine tract was replaced with a consensus U2AF65 binding site (UUUUUUCCCUUUUUUUUUC, as in [21]), and the IgMPyupward arrowDeltaE substrate, in which the enhancer was also deleted. To these substrates we added the PTB site I mutation, to create IgMPyupward arrowPTB and IgMPyupward arrowDeltaEPTB. IgMPyupward arrow and IgMPyupward arrowPTB could both be spliced in S100 complementation with either SF2/ASF or DeltaNDeltaRS (Figure 4, lanes 8 and 9, and lanes 20 and 21), but IgMPyupward arrowDeltaE, lacking an enhancer, could not be spliced with either protein (lanes 11 and 12). Although trace amounts of splicing were detectable for IgMPyupward arrowDeltaEPTB in S100 complementation with either SF2/ASF or DeltaNDeltaRS (Figure 4, lanes 23 and 24), we were largely unable to relieve the requirement for an ESE by simultaneously mutating the ESS and improving the polypyrimidine tract. However, there are notable differences between our experimental conditions and the manner in which the analogous experiment was carried out by Graveley et al, most important of which is that our experiment was an S100 complementation assay, rather than splicing in nuclear extract. In addition, our assay utilized IgM M1-M2 with a mutation in the PTB site I [45], rather than the IgM MS2 substrate [21], which does not have the silencer because it lacks most of exon M2 downstream of the enhancer.
###end p 30
###begin p 31
###xml 868 872 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen1">[27]</xref>
###xml 874 878 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen3">[45]</xref>
###xml 880 884 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley4">[59]</xref>
###xml 1018 1022 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen1">[27]</xref>
We conclude from these experiments that the ESE is required for splicing of IgM M1-M2 in S100 complementation with either SF2/ASF or DeltaNDeltaRS, suggesting that DeltaNDeltaRS, like SF2/ASF, exerts at least some of its effects to activate splicing from the position of the exonic splicing enhancer. Significantly, our data also suggest that the RS domain is not required for enhancer-dependent SR protein functions, at least in the context of IgM M1-M2, as the levels of splicing of IgM M1-M2 and IgM-derivative substrates with DeltaNDeltaRS were comparable to, or greater than, those observed with SF2/ASF. An RS domain tethered to the ESE position was found to be insufficient to activate splicing of an IgM substrate in S100 complementation assays, and the addition of an intact SR protein to the reaction is required for splicing to occur under these conditions [27], [45], [59]. An N-terminally His-tagged DeltaRS protein was found to be unable to perform ESE-independent SR protein function(s) in this context [27]; however, we demonstrate using DeltaNDeltaRS as the sole source of SR protein in our complementation assays that the RS domain is also not required for this additional SR protein function(s) to support splicing of IgM M1-M2.
###end p 31
###begin title 32
Discussion
###end title 32
###begin title 33
Possible mechanisms of inhibition of splicing by the N-terminus of SF2/ASF
###end title 33
###begin p 34
###xml 673 677 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cceres1">[40]</xref>
###xml 679 683 675 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zuo2">[41]</xref>
###xml 685 689 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Mayeda1">[62]</xref>
###xml 858 862 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zhu2">[42]</xref>
###xml 1434 1442 1418 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Historically, SR protein RS domains were thought to be essential for constitutive splicing, because a recombinant SR protein lacking its RS domain was unable to complement S100 for splicing of constitutive substrates. In retrospect, what these early experiments may have been demonstrating was the importance of sequences preceding RRM1 in influencing the ability of SR proteins to be recruited to pre-mRNA. Initial experiments to test whether the RS domain of SF2/ASF is required for splicing were carried out with versions of DeltaRS tagged at the N-terminus, and these experiments consistently showed that the RS domain of SF2/ASF was required for constitutive splicing [40], [41], [62]. Subsequent experiments using a version of DeltaRS with no tag at the N-terminus unexpectedly showed that the RS domain was dispensable for splicing of some substrates [42]. We have not ruled out the possibility that deletion of sequences from the N-terminus, including the N-terminal extension to RRM1, increase the ability of DeltaRS to bind to pre-mRNA and promote splicing merely by increasing solubility of the SR protein. Nonetheless, we now find that deletion of the majority of the amino acids preceding RRM1 in the context of the DeltaRS protein permits splicing even of the IgM M1-M2 pre-mRNA, a substrate previously classified as RS-domain-dependent, further demonstrating that the RS domain is dispensable for constitutive splicing in vitro.
###end p 34
###begin p 35
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Maris1">[46]</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Jacks1">[54]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-PrezCaadillas1">[55]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Allain1">[63]</xref>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g002">Figure 2</xref>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-He1">[64]</xref>
RRMs can have N-terminal and C-terminal extensions augmenting their core structure that are usually poorly ordered, but in some cases adopt a secondary structure [46]. In cases in which their functions have been documented, these N-terminal and C-terminal extensions of RRMs modulate nucleic acid binding by the core RRM. For some of these RRMs, the extensions can fold over onto the RNA-binding surface of the core domain to mask key residues involved in nucleic acid binding [54], [55], [63]. Several SR proteins, including SF2/ASF, have N-terminal extensions preceding their first RRM (Figure 2). The 20 available NMR structures of RRM1 of SF2/ASF [64] when viewed collectively hint that the N-terminal extension is probably flexible and can adopt many different conformations, such that this region could sometimes occlude key RNA-binding residues on the protein's beta-sheet. The observed flexibility of the N-terminal extension could be due in part to an additional hydrophilic-tag extension that was added for the purpose of improving solubility in the structure determination.
###end p 35
###begin p 36
###xml 563 572 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g003">Figure 3B</xref>
###xml 927 931 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Merrill1">[65]</xref>
###xml 1181 1185 1167 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cceres1">[40]</xref>
###xml 1187 1191 1173 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zuo2">[41]</xref>
###xml 1193 1197 1179 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Mayeda1">[62]</xref>
###xml 1381 1390 1363 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g001">Figure 1C</xref>
Based on our data and the documented functions of other RRM extensions, we propose that the most likely explanation for the inhibitory effect of amino acids 2-11 of SF2/ASF on splicing is that the N-terminal segment negatively affects RNA binding by RRM1. In this model, the N-terminal domain may be inhibitory by functioning as a damper upon RRM1 to interfere with its binding to the RNA. Indeed, we have observed in UV crosslinking assays that deletion of the N-terminal extension from DeltaRS greatly enhances apparent binding of the protein to IgM M1-M2 RNA (Figure 3B). These quantitative differences in crosslinking probably reflect differences in binding; although residues outside the beta-sheet could potentially crosslink also, the major sites of crosslinking likely involve conserved aromatic residues in the RNP-1 and RNP-2 core submotifs at the center of the beta-sheet, as has been shown for the RRMs of hnRNP A1 [65]. Addition of an N-terminal tag to DeltaRS may exacerbate the inhibitory effect of the natural N-terminus on RNA binding, accounting for the early observations that His-tagged SF2/ASF lacking its RS domain was unable to support constitutive splicing [40], [41], [62]. Curiously, the R8E mutation, but not the V6A/I7A/R8A or R8A mutations, abrogated the inhibitory effects of the N-terminus on the ability of DeltaRS to support splicing of IgM M1-M2 (Figure 1C). In a scenario in which the N-terminal extension of RRM1 prevents recruitment of DeltaRS to pre-mRNA by blocking access to key RNA-binding residues on the beta-sheet, substitution of the conserved arginine with an acidic residue, but not with an uncharged residue, may be sufficient to interfere with potential intramolecular interactions between the N-terminal extension preceding RRM1 and the RNA-binding surface of the protein.
###end p 36
###begin p 37
###xml 1173 1182 1157 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000854-g003">Figure 3B</xref>
We propose that in the context of the splicing reaction, the SF2/ASF RS domain normally assists in overcoming the inhibitory effect of the N-terminus, most probably by helping to recruit the RRM(s) to the RNA. Thus, one possible reason for the previously reported, apparent RS-domain-dependence of some substrates could be that in the context of these pre-mRNAs, binding of RRM1 of SF2/ASF is inhibited, due to unfavorable secondary structure of the pre-mRNA or steric block by proteins bound adjacent to the RRM1 target, or both; a hypophosphorylated RS domain might therefore assist in initial recruitment of SF2/ASF to its target, through its own charge-mediated contacts with adjacent RNA sequences, bringing in the N-terminal RRM region so that it can directly contact the RNA. In agreement with this hypothesis, using a UV crosslinking assay, we observed little difference between crosslinking of SF2/ASF and DeltaNSF2/ASF to IgM M1-M2 pre-mRNA, whereas the DeltaRS protein bound less efficiently to IgM M1-M2 than did either SF2/ASF or DeltaNSF2/ASF; however, when the N-terminal extension was deleted from DeltaRS, its binding to the pre-mRNA was greatly enhanced (Figure 3B).
###end p 37
###begin title 38
Constitutive splicing without an SR protein RS domain
###end title 38
###begin p 39
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zhu2">[42]</xref>
Our finding that the RS domain is not required for constitutive splicing of IgM M1-M2 seemingly contradicts prevailing models about how SR proteins function to promote splicing. The previous finding that the RS domain is dispensable for splicing of some substrates but not for others [42] hinted that SR proteins may activate splicing in a manner that does not always involve SR protein RS-domain-mediated protein-protein interactions. However, because some substrates were found to require the RS domain, RS-domain-mediated recruitment functions of SF2/ASF could not be formally discounted, and were still hypothesized to occur for RS-domain-dependent substrates. Splicing in the absence of an SR protein RS domain suggests two possibilities for how the domains of SR proteins function to promote pre-mRNA splicing from the ESE position. First, the RS domain may indeed be required in some contexts for recruitment functions of SR proteins, and in contexts where the protein is active in the absence of the RS domain, the DeltaRS portion of the protein may promote splicing by antagonizing the function of splicing silencers. Second, the DeltaRS portion of the protein may be sufficient to recruit splicing factors to activate splicing. As the number of constitutive substrates that can be spliced without an SR protein RS domain continues to grow, it seems increasingly improbable that SR proteins lacking their RS domains can only support splicing in contexts where recruitment functions of SR proteins are dispensable. Instead, it appears more likely that protein-protein interactions occurring through the RS domain of SR proteins are not essential for recruitment of splicing factors, a finding that seems at odds with current recruitment models for SR protein function.
###end p 39
###begin p 40
###xml 184 186 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley2">[21]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley3">[56]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley4">[59]</xref>
###xml 663 665 655 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 928 932 920 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Eperon1">[66]</xref>
###xml 1248 1252 1240 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Xiao1">[15]</xref>
###xml 1541 1545 1529 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Xiao1">[15]</xref>
###xml 1685 1689 1673 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Kohtz1">[13]</xref>
###xml 1691 1695 1679 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cao1">[67]</xref>
###xml 2052 2054 2040 2042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 2088 2090 2076 2078 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 2119 2122 2107 2110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley1">[3]</xref>
###xml 2124 2128 2112 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zuo1">[16]</xref>
###xml 2251 2255 2239 2243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zamore1">[68]</xref>
###xml 2257 2261 2245 2249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Rudner1">[69]</xref>
###xml 2263 2267 2251 2255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Rudner2">[70]</xref>
###xml 2294 2296 2282 2284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 2357 2361 2345 2349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Guth2">[44]</xref>
###xml 2418 2420 2406 2408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
The traditional recruitment models for SR protein function assume that the ESE-bound RS domain of an SR protein interacts with the RS domain of another splicing component, such as U2AF35 or U1-70K. Much support has been garnered for the SR protein RS domain-mediated recruitment model, through experiments that employed MS2-RS domain fusion proteins as splicing activators [21], [56], [59]. However, if our DeltaNDeltaRS protein is functioning to recruit other splicing components, it cannot be doing so through RS-RS domain interactions. Although there is evidence to suggest that SR proteins assist in the recruitment of essential splicing factors, such as U2AF35 or U1-70K, which themselves have RS domains, it is not clear that this recruitment requires the RS domains of both of the involved proteins. For example, the RS domain of SF2/ASF is not required for enhancement of U1 snRNP binding to alternative 5' splice sites [66], which is presumed to occur through an interaction with the RS-domain-containing protein U1-70K. Indeed, it is unlikely that the SF2/ASF RS domain can function to recruit U1 snRNP through interactions with U1-70K, as the isolated, unphosphorylated RS domain of SF2/ASF is not sufficient for interaction with U1-70K [15]. It seems more probable that some portion of SF2/ASF other than, or in addition to, the RS domain engages in protein-protein interactions with U1-70K to recruit U1 snRNP, considering that a GST-DeltaRS fusion protein can engage in RNA-independent protein-protein interactions with U1-70K [15]. Some labs have reported that at least one of the RS domains of SF2/ASF and U1-70K is required for interactions between these two proteins [13], [67], but these experiments did not demonstrate that the RS domains of both proteins were required for their interaction. The proposed recruitment function of SR proteins for which the most experimental evidence has been assembled is the model in which an ESE-bound SR protein engages via its RS domain in protein-protein interactions with the RS domain of U2AF35 to aid in the recruitment of U2AF65 to the polypyrimidine tract [3], [16]. However, several lines of evidence suggest that only one of these two U2AF RS domains is required for efficient splicing [68], [69], [70], and the RS domain of U2AF35 is dispensable for complementation of U2AF-depleted extract [44], leaving open the possibility that the RS domain of U2AF35 is likewise not needed for interaction with an ESE-bound SR protein.
###end p 40
###begin p 41
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cartegni2">[29]</xref>
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zhu2">[42]</xref>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley3">[56]</xref>
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zhu2">[42]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley3">[56]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen4">[57]</xref>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cartegni2">[29]</xref>
###xml 907 911 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zhu2">[42]</xref>
###xml 1586 1588 1578 1580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1742 1744 1734 1736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 1753 1755 1745 1747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1883 1887 1875 1879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Zamore1">[68]</xref>
###xml 1889 1893 1881 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Rudner1">[69]</xref>
###xml 1895 1899 1887 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Rudner2">[70]</xref>
###xml 2087 2091 2079 2083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley3">[56]</xref>
###xml 2093 2097 2085 2089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley4">[59]</xref>
###xml 2099 2103 2091 2095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Philipps1">[71]</xref>
###xml 2114 2116 2106 2108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 2116 2120 2108 2112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen1">[27]</xref>
###xml 2122 2126 2114 2118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen4">[57]</xref>
###xml 2128 2132 2120 2124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Philipps1">[71]</xref>
###xml 2138 2140 2130 2132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 2140 2144 2132 2136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen4">[57]</xref>
###xml 2146 2150 2138 2142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Philipps1">[71]</xref>
###xml 2159 2163 2151 2155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Philipps1">[71]</xref>
###xml 2195 2199 2187 2191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Cartegni2">[29]</xref>
###xml 2201 2205 2193 2197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen4">[57]</xref>
###xml 2207 2211 2199 2203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Philipps1">[71]</xref>
It has been demonstrated that an RS domain at the position of the ESE, whether synthetic [29], [42] or authentic [56], and whether targeted there via an SR protein RRM [42], a heterologous RNA-binding domain, such as the MS2 coat protein [56], [57], or an antisense oligonucleotide [29], can function to promote splicing, whether this splicing activation occurs from the ESE through influencing the recruitment of other splicing factors or by promoting base-pairing of U snRNAs to pre-mRNA. From these experiments we may conclude that one of the primary functions of ESEs is to recruit an RS domain. However, an ESE is still required for splicing of IgM M1-M2 with our DeltaNDeltaRS protein, which lacks an RS domain. Clearly, recruitment of an RS domain by any means to the position of the ESE can function to promote splicing, yet in conjunction with the previous report of RS-domain-independent splicing [42] our data strongly suggest that the SR protein RS domain is not required at this position to activate splicing. This apparent paradox can be resolved if we consider that the function of an SR protein may not be to recruit other splicing factors through its RS domain, but rather simply to recruit an RS domain, whether its own or the RS domain of another splicing factor. In an SR protein RS-domain-independent recruitment model, the SR protein would interact with another splicing factor, and this interaction must recruit at least one RS domain for splicing to be activated. An SR protein lacking its RS domain could activate splicing by interacting, for example, with U2AF35, which itself has an RS domain, or with U1-70K, which also has its own RS domain. Such a mechanism would be analogous to the situation described for U2AF65 and U2AF35, which interact with each other and both have RS domains, but only one of the two RS domains is required for splicing to occur [68], [69], [70]. Indeed, the requirements for the identity of the RS domain recruited to the ESE position to function as a splicing activator are far from stringent, as the RS domain from any SR protein [56], [59], [71], from U2AF65[27], [57], [71], U2AF35[57], [71], U1-70K [71], or even a synthetic RS domain [29], [57], [71] are all sufficient for this purpose.
###end p 41
###begin p 42
###xml 582 586 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Price1">[72]</xref>
###xml 588 592 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Kielkopf1">[73]</xref>
###xml 594 598 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Selenko1">[74]</xref>
Our data strongly suggest that SR protein RS-domain-mediated protein-protein interactions are not required for SR proteins to promote recruitment of other splicing factors. Alternatively, the DeltaRS portion of SF2/ASF, which consists of two RRMs separated by a glycine-rich linker, may itself be engaging in protein-protein interactions with other proteins of the spliceosome. There are precedents for this possibility, as several other essential splicing factors have already been demonstrated to interact with each other through protein-protein interactions involving their RRMs [72], [73], [74]. Using the DeltaNDeltaRS protein, the roles of portions of SR proteins other than their RS domains in promoting splicing can be explored in the future.
###end p 42
###begin title 43
Materials and Methods
###end title 43
###begin title 44
Cloning Procedures
###end title 44
###begin p 45
###xml 16 20 16 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Durocher1">[75]</xref>
The pTT3 vector [75] was employed for expression of C-terminally His-tagged SR proteins in 293-EBNA1 cells; plasmids pTT3-SF2His and pTT3-SF2DeltaRSCHis code for amino acids 1-248 and 1-196 of SF2/ASF, respectively. Plasmids for expression of N-terminus mutant proteins were created by deletion or mutation of sequences in the pTT3-SF2His and pTT3-SF2DeltaRSCHis plasmids, either as described in the Stratagene Quikchange Site-Directed Mutagenesis Kit manufacturer's protocol or using a site-directed mutagenesis strategy with a common reverse primer and mutagenic forward primers that overlap at their 5' ends with the reverse primer. The protein-coding regions for all protein expression plasmids were verified by sequencing.
###end p 45
###begin p 46
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-PontKingdon1">[76]</xref>
###xml 396 400 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Watakabe1">[58]</xref>
###xml 810 814 791 795 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UUUU</underline>
###xml 815 817 796 798 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UC</underline>
###xml 818 820 799 801 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CU</underline>
###xml 821 822 802 803 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</underline>
###xml 823 827 804 808 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UUUU</underline>
###xml 828 829 809 810 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 832 836 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Graveley2">[21]</xref>
###xml 1082 1086 1055 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Kan1">[23]</xref>
###xml 1207 1208 1176 1177 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 1209 1210 1178 1179 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 1214 1215 1183 1184 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 1216 1217 1185 1186 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 1221 1225 1190 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Shen3">[45]</xref>
Plasmids containing transcription templates for IgM M1-M2 splicing substrates with mutations or deletions in the polypyrimidine tract, exonic splicing enhancer, and/or exonic splicing silencer were generated by either overlap-extension PCR or site-directed mutagenesis. Overlap-extension PCR [76] was carried out using Pfu Turbo polymerase (Stratagene), using outside primers to pSP65-microM1-M2 [58] upstream of the SP6 transcription start site and downstream of the XbaI site used for the transcription runoffs. Overlapping PCR products were cloned into the pCR-Blunt vector (Invitrogen). All transcription templates were verified by sequencing. IgMPyupward arrow was generated by overlap-extension PCR with pSP65-microM1-M2 as a template, using inside primers to introduce the mutant polypyrimidine tract 5'UUUUUUCCCUUUUUUUUUC3' [21] in place of the wild-type polypyrimidine tract 5'ACACUGUCUCUGUCACCUG3'. IgMDeltaE was generated by overlap-extension PCR with pSP65-microM1-M2 as a template, using inside primers to delete the 23-nt enhancer 5'GAAGGACAGCAGAGACCAAGA3' in exon M2 [23]. IgMPTB was generated by site-directed mutagenesis of the pSP65-microM1-M2 plasmid to introduce the mutant PTB site I 5'ACAUACGACAU3' [45] in place of the wild-type site 5'UCUUACGUCUU3'. IgMPyupward arrowDeltaE was generated by overlap-extension PCR with pCR-Blunt-IgMDeltaE as a template, using inside primers as described above to introduce the mutant polypyrimidine tract in place of the wild-type polypyrimidine tract. IgMDeltaEPTB, IgMPyupward arrowPTB, and IgMPyupward arrowDeltaEPTB were generated by site-directed mutagenesis of the pCR-Blunt-IgMDeltaE, pCR-Blunt-IgMPyupward arrow and pCR-Blunt-IgMPyupward arrowDeltaE plasmids, respectively to introduce the mutant PTB site I as described above.
###end p 46
###begin title 47
Protein Expression and Purification
###end title 47
###begin p 48
###xml 277 281 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Durocher1">[75]</xref>
###xml 372 373 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 571 572 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 484 488 <span type="species:ncbi:9913">calf</span>
SF2/ASF, DeltaRS, and N-terminus mutant proteins were expressed as C-terminally His-tagged fusion proteins from the pTT3-SF2His and pTT3-SF2DeltaRSCHis plasmids or derivatives of these plasmids, respectively, after transfection with polyethylenimine (PEI) into 293-EBNA1 cells [75]. 293-EBNA1 cells (Invitrogen) were maintained in suspension culture at a density of 2.5x105 cells/mL in MEM Joklik's suspension modification medium with L-glutamine (US Biological) supplemented with 5% calf serum (Gibco) and penicillin/streptomycin. For transfection, 1L of cells at 2.5x105 cells/mL were allowed to grow for 24 hours and then transfected by the addition of 1 mg of plasmid, 50 mL of culture medium, and 2 mg of PEI linear MW = 25,000 (Polysciences) to the suspension cell culture.
###end p 48
###begin p 49
After transfection, cultures were grown for three days to allow for protein expression. Pelleted cells were washed with PBS and resuspended in a lysis buffer consisting of 1 M NaCl, 0.1% v/v Triton X-100, 20 mM beta-mercaptoethanol, 50 mM TRIS-HCl pH 8.0, 10 mM imidazole, supplemented with the EDTA-free Complete Mini protease inhibitor tablet (Roche) prior to sonication. The sonicate was centrifuged at 15,000 rpm, and a 0-30% saturated ammonium sulfate cut was carried out on the supernatant, followed by another 15,000 rpm centrifugation. The second supernatant was diluted with an equal volume of lysis buffer without salt and then incubated at 4degreesC with Ni-NTA agarose beads (Qiagen) in batch. Beads were washed on a column with 50 volumes of lysis buffer without Triton X-100, and proteins were eluted in lysis buffer with 1 M NaCl and 300 mM imidazole and without Triton X-100. After elution from the Ni-NTA agarose column, fractions containing SR protein were combined. If the protein concentration was at least 3 mg/mL for the pooled peak fractions, proteins were directly dialyzed twice against Buffer D, consisting of 20 mM HEPES-KOH pH 8.0, 0.2 mM EDTA, 20% (v/v) glycerol, 0.4 M KCl, 1 mM DTT, and 0.5 mM PMSF. If the protein concentration was less than 3 mg/mL after combining peak fractions, proteins were denatured by dialyzing into Buffer D with 6 M urea at 0.1 M KCl, and then concentrated at 4degreesC to approximately 3 mg/mL using a Centricon-10 concentration device (Millipore Corporation). Concentrated proteins were refolded by sequential dialyses in Buffer D containing 3 M urea and 0.4 M KCl, 1.5 M urea and 0.4 M KCl, 0.75 M urea and 0.4 M KCl, and finally into Buffer D.
###end p 49
###begin title 50
In Vitro Splicing Assays
###end title 50
###begin p 51
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Mayeda2">[77]</xref>
###xml 214 216 214 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7m</sup>
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Mayeda3">[78]</xref>
###xml 343 351 343 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000854-Mayeda4">[79]</xref>
###xml 563 564 559 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 579 581 571 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Splicing substrates were transcribed from plasmid templates linearized with XbaI using SP6 RNA polymerase (Promega), essentially as described in [77], except that G(5')ppp(5')G cap analog (NEB) was used instead of 7mGpppG cap analog. All transcripts were gel-purified. HeLa cell cytoplasmic (S100) extracts were prepared as described in [78]. In vitro splicing assays were carried out essentially as described in [79]. Briefly, 10-microL reactions containing 0.5 mM ATP, 20 mM creatine phosphate, 20 mM HEPES-KOH pH 7.3, 2.6 % (w/v) polyvinyl alcohol, 1.6 mM MgCl2, 20 fmol alpha32P-UTP labeled splicing substrate, 30% (v/v) S100, and 16 pmol SR protein were set up on ice. For S100 complementation reactions with SR proteins in 0.4 M KCl Buffer D, the final salt concentration for the splicing reaction was adjusted to 60 mM using Buffer D without salt. Splicing reactions were incubated at 30degreesC, followed by phenol extraction and ethanol precipitation. RNA was resuspended in formamide/bromophenol blue/xylene cyanol FF loading dye, and separated in a 5.5% acrylamide/8.3 M urea gel. Bands were visualized by autoradiography using X-OMAT film (Kodak) or by exposure to a FUJI PhosphorImager screen and analysis with an Image Reader FLA-5100 (FujiFilm Medical Systems, Stamford, Connecticut, United States). Percent splicing was calculated as [mRNA/(mRNA+pre-mRNA)]x100.
###end p 51
###begin title 52
UV Crosslinking
###end title 52
###begin p 53
###xml 226 227 222 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 413 414 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 802 803 780 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Protein binding was performed in 20-microL reactions containing 32 pmol of SR protein or BSA, 80 fmol of uncapped IgM M1-M2 RNA labeled with all four NTPs, in reaction buffer conditions with final concentrations of 1.6 mM MgCl2, 20 mM HEPES-KOH pH 7.3, 0.5 mM ATP, 20 mM creatine phosphate, and 60 mM KCl. RNA was denatured prior to incubation with protein; RNA mixes containing 80 fmol of labeled IgM M1-M2, MgCl2, and water were assembled at 4degreesC, heated at 95degreesC for five minutes, and then returned to ice. 32 pmol of BSA or SR protein in Buffer D was then added to each reaction along with the other splicing buffer components, and reactions were incubated at 30degreesC for 30 minutes. Binding reactions were spotted onto parafilm and placed on ice prior to UV crosslinking at 0.864 J/cm2 in a Spectrolinker XL-1000 UV Crosslinker (Spectronics Corporation). Reactions were returned to Eppendorf tubes, and 3 microL of 27 mg/mL RNAse A and 2 microL of 1000 U/microL RNAse T1 (Roche) were added prior to incubation at 37degreesC for 15 minutes. Proteins and RNA were separated by 12% SDS-PAGE prior to visualization by autoradiography and phosphorimaging.
###end p 53
###begin p 54
###xml 39 48 <span type="species:ncbi:35936">Carmelita</span>
We would like to thank Jeanne Wiggins, Carmelita Bautista, and Margaret Falkowski for assistance with HeLa suspension cell culture and cell culture media, Phil Smith for the pTT3-SF2His plasmid, and Zuo Zhang for the pTT3-SF2DeltaRSCHis plasmid.
###end p 54
###begin title 55
References
###end title 55
###begin article-title 56
SR proteins: a conserved family of pre-mRNA splicing factors.
###end article-title 56
###begin article-title 57
Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors.
###end article-title 57
###begin article-title 58
Sorting out the complexity of SR protein functions.
###end article-title 58
###begin article-title 59
Listening to silence and understanding nonsense: exonic mutations that affect splicing.
###end article-title 59
###begin article-title 60
###xml 71 76 <span type="species:ncbi:9606">human</span>
Exonic splicing enhancers: mechanism of action, diversity, and role in human genetic diseases.
###end article-title 60
###begin article-title 61
###xml 45 50 <span type="species:ncbi:9606">human</span>
Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.
###end article-title 61
###begin article-title 62
Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins.
###end article-title 62
###begin article-title 63
SR proteins and splicing control.
###end article-title 63
###begin article-title 64
The superfamily of arginine/serine-rich splicing factors.
###end article-title 64
###begin article-title 65
Molecular basis of RNA recognition and TAP binding by the SR proteins SRp20 and 9G8.
###end article-title 65
###begin article-title 66
Initial splice-site recognition and pairing during pre-mRNA splicing.
###end article-title 66
###begin article-title 67
Specific interactions between proteins implicated in splice site selection and regulated alternative splicing.
###end article-title 67
###begin article-title 68
Protein-protein interactions and 5' splice-site recognition in mammalian mRNA precursors.
###end article-title 68
###begin article-title 69
SR proteins promote the first specific recognition of pre-mRNA and are present together with U1 snRNP in a general splicing enhancer complex.
###end article-title 69
###begin article-title 70
Phosphorylation of the ASF/SF2 RS domain affects both protein-protein interactions and is necessary for splicing.
###end article-title 70
###begin article-title 71
The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing.
###end article-title 71
###begin article-title 72
Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity.
###end article-title 72
###begin article-title 73
Role of the constitutive splicing factors U2AF65 and SAP49 in suboptimal RNA splicing of novel retroviral mutants.
###end article-title 73
###begin article-title 74
A splicing enhancer exhibits both constitutive and regulated activities.
###end article-title 74
###begin article-title 75
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN.
###end article-title 75
###begin article-title 76
The role of U2AF35 and U2AF65 in enhancer-dependent splicing.
###end article-title 76
###begin article-title 77
Distinct factor requirements for exonic splicing enhancer function and binding of U2AF to the polypyrimidine tract.
###end article-title 77
###begin article-title 78
Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor.
###end article-title 78
###begin article-title 79
RS domains contact the pre-mRNA throughout spliceosome assembly.
###end article-title 79
###begin article-title 80
Silencers regulate both constitutive and alternative splicing events in mammals.
###end article-title 80
###begin article-title 81
Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNPA1 and enhancer-bound SR proteins.
###end article-title 81
###begin article-title 82
A pathway of sequential arginine-serine rich domain-splicing signal interactions during mammalian spliceosome assembly.
###end article-title 82
###begin article-title 83
###xml 82 87 <span type="species:ncbi:4932">yeast</span>
###xml 96 102 <span type="species:ncbi:9606">humans</span>
RS domains contact splicing signals and promote splicing by a common mechanism in yeast through humans.
###end article-title 83
###begin article-title 84
Correction of disease-associated exon skipping by synthetic exon-specific activators.
###end article-title 84
###begin article-title 85
Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors.
###end article-title 85
###begin article-title 86
Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
###end article-title 86
###begin article-title 87
The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
###end article-title 87
###begin article-title 88
Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature
###end article-title 88
###begin article-title 89
A serine kinase regulates intracellular localization of splicing factors in the cell cycle.
###end article-title 89
###begin article-title 90
Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo.
###end article-title 90
###begin article-title 91
Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2.
###end article-title 91
###begin article-title 92
Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins.
###end article-title 92
###begin article-title 93
The protein kinase Clk/Sty directly modulates SR protein activity: Both hyper- and hypophosphorylation inhibit splicing.
###end article-title 93
###begin article-title 94
Developmental regulation of SR protein phosphorylation and activity.
###end article-title 94
###begin article-title 95
Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains.
###end article-title 95
###begin article-title 96
###xml 26 31 <span type="species:ncbi:9606">human</span>
Functional domains of the human splicing factor ASF/SF2.
###end article-title 96
###begin article-title 97
Pre-mRNA splicing in the absence of an SR protein RS domain.
###end article-title 97
###begin article-title 98
Evidence for substrate-specific requirement of the splicing factor U2AF(35) and for its function after polypyrimidine tract recognition by U2AF(65).
###end article-title 98
###begin article-title 99
Dual function for U2AF(35) in AG-dependent pre-mRNA splicing.
###end article-title 99
###begin article-title 100
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
A single polypyrimidine tract binding protein (PTB) binding site mediates splicing inhibition at mouse IgM exons M1 and M2.
###end article-title 100
###begin article-title 101
The RNA recognition motif, a plastic RNA binding platform to regulate post-transcriptional gene expression.
###end article-title 101
###begin article-title 102
A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K U1 snRNP protein.
###end article-title 102
###begin article-title 103
Crystal structure of the RNA-binding domain of the U1 small nuclear ribonucleoprotein A.
###end article-title 103
###begin article-title 104
Crystal structure at 1.92 A resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin.
###end article-title 104
###begin article-title 105
Identification of molecular contacts between the U1 A small nuclear ribonucleoprotein and U1 RNA.
###end article-title 105
###begin article-title 106
Structure and RNA interactions of the N-terminal RRM domains of PTB.
###end article-title 106
###begin article-title 107
The determinants of RNA-binding specificity of the heterogeneous nuclear ribonucleoprotein C proteins.
###end article-title 107
###begin article-title 108
Crystal structure of the two-RRM domain of hnRNP A1 (UP1) complexed with single-stranded telomeric DNA.
###end article-title 108
###begin article-title 109
###xml 38 43 <span type="species:ncbi:9606">human</span>
Structure of the C-terminal domain of human La protein reveals a novel RNA recognition motif coupled to a helical nuclear retention element.
###end article-title 109
###begin article-title 110
###xml 62 67 <span type="species:ncbi:9606">human</span>
Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein.
###end article-title 110
###begin article-title 111
A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers.
###end article-title 111
###begin article-title 112
Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly.
###end article-title 112
###begin article-title 113
The role of exon sequences in splice site selection.
###end article-title 113
###begin article-title 114
Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing.
###end article-title 114
###begin article-title 115
Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.
###end article-title 115
###begin article-title 116
###xml 46 63 <span type="species:ncbi:12026">bacteriophage R17</span>
Selection of high affinity RNA ligands to the bacteriophage R17 coat protein.
###end article-title 116
###begin article-title 117
Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements.
###end article-title 117
###begin article-title 118
Specificity of ribonucleoprotein interaction determined by RNA folding during complex formation.
###end article-title 118
###begin article-title 119
Solution structure of RRM domain in splicing factor SF2.
###end article-title 119
###begin article-title 120
Phenylalanines that are conserved among several RNA-binding proteins form part of a nucleic acid-binding pocket in the A1 heterogeneous nuclear ribonucleoprotein.
###end article-title 120
###begin article-title 121
Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1.
###end article-title 121
###begin article-title 122
###xml 37 42 <span type="species:ncbi:9606">human</span>
A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding.
###end article-title 122
###begin article-title 123
Cloning and domain structure of the mammalian splicing factor U2AF.
###end article-title 123
###begin article-title 124
###xml 113 123 113 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 113 123 <span type="species:ncbi:7227">Drosophila</span>
Molecular genetic analysis of the heterodimeric splicing factor U2AF: the RS domain on either the large or small Drosophila subunit is dispensable in vivo.
###end article-title 124
###begin article-title 125
RNA binding activity of heterodimeric splicing factor U2AF: at least one RS domain is required for high affinity binding.
###end article-title 125
###begin article-title 126
Arginine/serine repeats are sufficient to constitute a splicing activation domain.
###end article-title 126
###begin article-title 127
Crystal structure of the spliceosomal U2B"-U2A' protein complex bound to a fragment of U2 small nuclear RNA.
###end article-title 127
###begin article-title 128
###xml 79 81 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65 </sup>
A novel peptide recognition mode revealed by the x-ray structure of a core U2AF35/U2AF65 heterodimer.
###end article-title 128
###begin article-title 129
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65 </sup>
###xml 55 60 <span type="species:ncbi:9606">human</span>
Structural basis for the molecular recognition between human splicing factors U2AF65 and SF1/mBBP.
###end article-title 129
###begin article-title 130
###xml 110 115 <span type="species:ncbi:9606">human</span>
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells.
###end article-title 130
###begin article-title 131
Creation of chimeric junctions, deletions, and insertions by PCR.
###end article-title 131
###begin article-title 132
Short donor site sequences inserted within the intron of beta-globin pre-mRNA serve for splicing in vitro.
###end article-title 132
###begin article-title 133
Preparation of Hela cell nuclear and cytosolic S100 extracts for in vitro splicing.
###end article-title 133
###begin article-title 134
Mammalian in vitro splicing assays.
###end article-title 134
###begin p 135
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 135
###begin p 136
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH grant GM42699 to ARK.
###end p 136

